تعداد نشریات | 418 |
تعداد شمارهها | 9,997 |
تعداد مقالات | 83,560 |
تعداد مشاهده مقاله | 77,800,502 |
تعداد دریافت فایل اصل مقاله | 54,843,309 |
Treatment with convalescent plasma for COVID-19 with respect to experience from prior coronavirus epidemics | ||
International Journal of Molecular and Clinical Microbiology | ||
دوره 10، شماره 1، شهریور 2020، صفحه 1312-1317 اصل مقاله (123 K) | ||
نوع مقاله: Short Communication | ||
نویسندگان | ||
Shahryar Pourkalhor1؛ Farimah Masoumi* 2 | ||
1School of medicine, Tonekabon Branch, Islamic azad university, Tonekabon, Iran Interest Group of CoronaVirus 2019 (IGCV-19), Universal Scientific Education and Research Network (USERN), Tehran, Iran | ||
2School of medicine, Tonekabon Branch, Islamic azad university, Tonekabon, Iran | ||
چکیده | ||
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a major concern all over the world. There is currently no proven vaccine and specific treatment to be effective for SARS-CoV-2 infection. Convalescent plasma obtained from patients who have recently recovered from infection has been used as a therapeutic intervention in previous coronavirus-related pandemics including SARS-CoV, MERS-CoV, and now COVID-19. The presence of neutralizing antibodies which specifically recognize SARS-CoV-2 are thought to mediate antiviral effects before patient develop their own humoral immune responses leading to cytokine storm and disease severity. In this review, we have summarized existing literature on convalescent plasma for the treatment of MERS-CoV, SARS-CoV, and COVID-19. Data from studies using convalescent plasma in COVID-19 suggest clinical improvements such as reduced viral load, oxygen requirement, and radiographic resolution. Although randomized clinical trials describing the benefit of convalescent plasma in COVID-19 are limited but these studies point to better outcomes of convalescent plasma treatment when administered earlier in the course of the disease. However, more precise randomized trials are needed to investigate different indications such as time of plasma administration and/or combination with other antiviral treatments. | ||
کلیدواژهها | ||
SARS-CoV-2؛ Convalescent Plasma؛ COVID-19؛ Coronavirus؛ Treatment | ||
آمار تعداد مشاهده مقاله: 163 تعداد دریافت فایل اصل مقاله: 130 |